| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |